Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for PPJ Healthcare Enterprises's Debt-to-EBITDA or its related term are showing as below:
PPJE's Debt-to-EBITDA is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.19 * Ranked among companies with meaningful Debt-to-EBITDA only.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
PPJ Healthcare Enterprises Debt-to-EBITDA Related Terms
PPJ Healthcare Enterprises Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PPJE vs LOGQ, MDFI, NMXS: Debt-to-EBITDA Comparison
For the Health Information Services subindustry, PPJ Healthcare Enterprises's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PPJ Healthcare Enterprises Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PPJ Healthcare Enterprises's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where PPJ Healthcare Enterprises's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is one times the quarterly (Dec. 2009) EBITDA data.
PPJ Healthcare Enterprises (PPJE) has a Debt-to-EBITDA of 0.02 as of Dec. 2009. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on PPJ Healthcare Enterprises.
Is PPJ Healthcare Enterprises' Debt-to-EBITDA too high?
PPJ Healthcare Enterprises' current Debt-to-EBITDA is 0.02. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.19. PPJ Healthcare Enterprises' value of 0.02 is 99.1% below this industry median.
How does PPJ Healthcare Enterprises' Debt-to-EBITDA compare to LOGQ and MDFI?
PPJ Healthcare Enterprises' Debt-to-EBITDA of 0.02 can be compared against companies in the Healthcare Providers & Services industry. The industry median Debt-to-EBITDA is 2.19. PPJ Healthcare Enterprises' value of 0.02 is 99.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.19, based on 478 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PPJ Healthcare Enterprises's current Debt-to-EBITDA of 0.02 is 99.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on PPJ Healthcare Enterprises. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PPJ Healthcare Enterprises's current Debt-to-EBITDA is 0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PPJ Healthcare Enterprises stock overvalued right now?
PPJ Healthcare Enterprises (PPJE) has a current Debt-to-EBITDA of 0.02. The current Debt-to-EBITDA is 0.02 and 99.1% below the Healthcare Providers & Services industry median of 2.19. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For PPJ Healthcare Enterprises (PPJE), the current Debt-to-EBITDA is 0.02 as of Dec. 2009. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PPJ Healthcare Enterprises Inc engages in joint venturing with doctors in setting up new practices, marketing, and management of pain management practices and blood culture labs. The company also engages in the development and testing of medical marijuana, medical cannabis products, and medical billing specialties in anesthesiology. The projects of the company include automated biller, medical billing service, pain management center, and Lab testing.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PPJE has been successfully added to your 
